Opinion: SA can’t afford proposed cuts to HIV funding

National Treasury has proposed a R1 billion cut to HIV funding. This has come about because – rather than seeing the reduced price of antiretroviral treatment as an opportunity to scale up treatment coverage and strengthen other interventions to address the HIV epidemic – the Department of Health has seen it as an opportunity for cost-containment. However, the HIV epidemic is not over and savings owing to cost reductions should not simply be returned to Treasury, argue Matshidiso Lencoasa and Mila Harding.

Read More

Interview: From a pig farm in Zim to star HIV researcher- Prof LGB reflects on her remarkable journey

Inside Professor Linda-Gail Bekker’s office a bookshelf is stacked with titles on general medicine, HIV and tuberculosis. Against the bookshelf, a mannequin leans dressed in a white doctor’s coat, sparkling tiara and pink Venetian mask, with a stethoscope protruding from her pocket. Known to colleagues as LGB, Bekker is one of South Africa’s top HIV researchers. Biénne Huisman chatted to Bekker about her remarkable career, finding new ways to reach young people, her love of both art and science and the thinking behind the slogan “get ripped, get prepped”.

Read More

In-depth: What new WHO TB numbers mean for SA

An estimated 54 000 people died of tuberculosis in South Africa in 2022 and around 280 000 fell ill with the disease, according to just-released figures from the World Health Organization. Catherine Tomlinson unpacks the figures and what they mean for the country’s TB response.

Read More

Free State bottom of the list when it comes to multi-month dispensing of ARVs, survey finds

The latest report published by community-led clinic monitoring group Ritshidze shows that the Free State is the worst-performing province in South Africa when it comes to giving people enough antiretrovirals to last several months at a time. This means people living with HIV in the province have to go collect their medicines more frequently than people in other provinces. Refilwe Mochoari reports.

Read More

OPINION: A new African HIV Control Working Group to propel African voices in the global HIV response

It is estimated that over 65% of the global HIV burden is in sub-Saharan Africa. Now, in an attempt to propel African voices and perspectives in the next phase of the HIV response in Africa, a group of Africans established an African-led HIV control working group (HCWG). They are all experts from the continent who have come together to develop consensus perspectives on the long-term sustained control of HIV and prioritise the systems and capabilities to achieve it. Drs Yogan Pillay and Izukanji Sikazwe explain the thinking behind the new working group and set out their objectives.

Read More

The good doctor: Mark Blaylock on finding meaning back at Manguzi

In December 2008, Dr Mark Blaylock left South Africa after a high-profile spat with then-Health MEC of KwaZulu-Natal Peggy Nkonyeni. The affair was sparked by Blaylock’s colleague Colin Pfaff being charged with misconduct for sourcing funding for antiretroviral drugs for pregnant women living with HIV. Four years later, Blaylock was back at Manguzi District Hospital in KwaZulu-Natal. Sue Segar chatted to Blaylock about his years outside of South Africa, returning to Manguzi, and how healthcare in KwaZulu-Natal has changed over the years.

Read More

Feature: The complexities of traditional and medical circumcision in the Eastern Cape

While most male circumcisions performed in the Eastern Cape are done in the traditional manner, there are also significant numbers of medical male circumcisions being conducted. Siyabonga Kamnqa reports on this year’s winter initiation season in the province and the complex interplay between culture, safety, and protection against HIV involved in deciding between the two types of circumcision.

Read More

Statin lowers cardio risk in people living with HIV, large study finds

Study findings presented this week at a major HIV conference show that taking a statin every day substantially reduces the chances of suffering a major adverse cardiovascular event in people living with HIV who have a low-to-moderate risk of cardiovascular disease. The findings were also published in the New England Journal of Medicine. Elri Voigt unpacks the study findings and asks what it might mean for people in South Africa.

Read More

Opinion: HIV investments remain no-brainers, but some things need to change

HIV in South Africa is not the crisis it was 20 years ago, and the country faces a growing burden of non-communicable diseases, but specific investments in HIV nevertheless continue to offer excellent value for money for governments and donors alike. As people gather for the 2023 International AIDS Society Conference in Brisbane, Australia, Marcus Low argues that while funding for HIV interventions remains absolutely essential, it is also critical for the future of the HIV response and people living with HIV that HIV should now be better integrated with other healthcare services, especially those for diabetes and hypertension.

Read More